Related Experiment Videos
HPA axis function during adjunctive high-dose dexamethasone use in chemotherapy: a prospective pilot study
Elżbieta Turska1, Krzysztof Lewandowski2, Igor Symonowicz1
1Department of Oncology, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.
Introduction:
Glucocorticoid-induced adrenal insufficiency is a well-known adverse effect of glucocorticoid therapy, occurring not only with oral administration but also with intramuscular, inhaled, and other routes of administration. However, the impact of intermittent high-dose glucocorticoids used during chemotherapy on hypothalamic-pituitary-adrenal (HPA) axis function remains incompletely understood.
Methods:
In this prospective pilot study, 47 women with breast cancer receiving paclitaxel-based chemotherapy with dexamethasone premedication were evaluated. Morning serum cortisol and adrenocorticotropic hormone (ACTH) concentrations were measured before dexamethasone administration at baseline and prior to subsequent weekly chemotherapy cycles. Longitudinal trends in cortisol and ACTH concentrations were analyzed using ANOVA and Spearman correlation.
Results:
Across the entire group, morning cortisol and ACTH concentrations showed an overall downward tendency during treatment. However, no statistically significant changes were observed. The results did not demonstrate significant suppression of morning cortisol or ACTH concentrations during intermittent high-dose dexamethasone administration in this group.
Discussion:
These findings underline the limitations of single cortisol measurements and highlight the need for a longitudinal approach when assessing adrenal function in oncology patients. Further studies incorporating dynamic testing are required to determine the optimal method for evaluating HPA axis function during intermittent glucocorticoid exposure.
Related Concept Videos
Hypothalamic-Pituitary Axis
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Cushing Syndrome II: Pathophysiology